AngioLab (XKRX:251280) Price-to-Tangible-Book : 13.18 (As of May. 26, 2024)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Price-to-Tangible-Book?

As of today (2024-05-26), AngioLab's share price is ₩6000.00. AngioLab's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was ₩455.17. Hence, AngioLab's Price to Tangible Book Ratio of today is 13.18.

The historical rank and industry rank for AngioLab's Price-to-Tangible-Book or its related term are showing as below:

XKRX:251280' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.55 Med: 10.92 Max: 16.65
Current: 13.18

During the past 7 years, AngioLab's highest Price to Tangible Book Ratio was 16.65. The lowest was 4.55. And the median was 10.92.

XKRX:251280's Price-to-Tangible-Book is ranked worse than
92.06% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs XKRX:251280: 13.18

A closely related ratio is called PB Ratio. As of today, AngioLab's share price is ₩6000.00. AngioLab's Book Value per Sharefor the quarter that ended in Dec. 2023 was ₩477.33. Hence, AngioLab's P/B Ratio of today is 12.57.

AngioLab Price-to-Tangible-Book Historical Data

The historical data trend for AngioLab's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Price-to-Tangible-Book Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

15.09

4.55

6.75

16.65

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	15.09	4.55	6.75	16.65

Competitive Comparison of AngioLab's Price-to-Tangible-Book

For the Biotechnology subindustry, AngioLab's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioLab's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AngioLab's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where AngioLab's Price-to-Tangible-Book falls into.

AngioLab Price-to-Tangible-Book Calculation

AngioLab's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	6000.00	/	455.174
	=	13.18

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

AngioLab Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of AngioLab's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines